Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cyclopentamine |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|
Phenylephrine (substance) |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|
Xylometazoline (substance) |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|
Pseudoephedrine (substance) |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|
Oxymetazoline (substance) |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|
Phenylpropanolamine (substance) |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|
bivirkning af mærkevarepræparat mod kongestion |
Causative agent |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
allergi over for navnebeskyttet præparat mod kongestion |
Causative agent |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
menthol 35,55 mg inhalationspulver kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
Tramazoline hydrochloride+dexamethasone isonicotinate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
Product containing precisely ephedrine hydrochloride 5 milligram/1 milliliter conventional release nasal drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 10 mg/mL nasal drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
navnebeskyttede midler mod tilstoppet næse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
præparat mod kongestion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
præparat mod næsekongestion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
tramazolinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
Systemic nasal decongestants |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
Ephedrine systemic decongestants |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
Topical Nasal decongestants |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
Compound Nasal decongestants |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
Ephedrine sulfate 2.5 mg/mL nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
Dexamethasone isonicotinate 20 microgram and tramazoline hydrochloride 120 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
Tramazoline (substance) |
Is a |
False |
Decongestant (substance) |
Inferred relationship |
Some |
|
allergi over for navnebeskyttet præparat mod kongestion |
Causative agent |
False |
Decongestant (substance) |
Inferred relationship |
Some |
1 |
Adverse reaction caused by decongestant (disorder) |
Causative agent |
True |
Decongestant (substance) |
Inferred relationship |
Some |
1 |
Allergy to decongestant |
Causative agent |
False |
Decongestant (substance) |
Inferred relationship |
Some |
2 |
Phenylephrine hydrochloride |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|
Pseudoephedrine hydrochloride (substance) |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|
Phenylpropanolamine hydrochloride |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|
Xylometazoline hydrochloride |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|
Pseudoephedrine sulfate |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|
Phenylephrine bitartrate |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|
Oxymetazoline hydrochloride |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|
Phenylephrine tannate |
Is a |
True |
Decongestant (substance) |
Inferred relationship |
Some |
|